-
1دورية أكاديمية
المؤلفون: Lee, CK, Friedlander, ML, Tjokrowidjaja, A, Ledermann, JA, Coleman, RL, Mirza, MR, Matulonis, UA, Pujade-Lauraine, E, Bloomfield, R, Goble, S, Wang, P, Glasspool, RM, Scott, CL
المصدر: Cancer , 127 (14) pp. 2432-2441. (2021)
مصطلحات موضوعية: BRCA mutation, homologous recombination deficiency, meta‐analysis, platinum‐sensitive recurrent ovarian cancer, poly(ADP‐ribose) polymerase inhibitorss
وصف الملف: text
العلاقة: https://discovery.ucl.ac.uk/id/eprint/10125655/1/CNCR-21-0218.R1_revision.pdfTest; https://discovery.ucl.ac.uk/id/eprint/10125655Test/
-
2دورية أكاديمية
المؤلفون: Antill, Y, Buchanan, DD, Scott, CL
العلاقة: NHMRC/1194896; Antill, Y., Buchanan, D. D. & Scott, C. L. (2021). Mismatch repair and clinical response to immune checkpoint inhibitors in endometrial cancer. CANCER, 128 (6), pp.1157-1161. https://doi.org/10.1002/cncr.34024Test.; http://hdl.handle.net/11343/315838Test
-
3دورية أكاديمية
المؤلفون: Jung, M, Gao, J, Cheung, L, Bongers, A, Somers, K, Clifton, M, Ramsay, EE, Russell, AJ, Valli, E, Gifford, AJ, George, J, Kennedy, CJ, Wakefield, MJ, Topp, M, Ho, GY, Scott, CL, Bowtell, DD, deFazio, A, Norris, MD, Haber, M, Henderson, MJ
المصدر: urn:ISSN:0020-7136 ; urn:ISSN:1097-0215 ; International Journal of Cancer, 147, 8, 2225-2238
مصطلحات موضوعية: Cancer, Ovarian Cancer, Rare Diseases, Orphan Drug, 5.1 Pharmaceuticals, 5 Development of treatments and therapeutic interventions, Carcinoma, Endometrioid, Ovarian Epithelial, Cell Line, Tumor, Cell Movement, Cell Proliferation, Cystadenocarcinoma, Serous, Drug Resistance, Neoplasm, Female, Gene Expression Regulation, Neoplastic, Genes, myc, Humans, Multidrug Resistance-Associated Proteins, Ovarian Neoplasms, Prognosis, RNA, Small Interfering, Survival Rate, ABCC4/MRP4
وصف الملف: application/pdf
العلاقة: http://purl.org/au-research/grants/nhmrc/APP1067110Test; http://hdl.handle.net/1959.4/unsworks_80419Test; https://unsworks.unsw.edu.au/bitstreams/cafa378b-e566-4efa-bf72-bbc3cca5523e/downloadTest; https://doi.org/10.1002/ijc.33005Test
الإتاحة: https://doi.org/10.1002/ijc.33005Test
http://hdl.handle.net/1959.4/unsworks_80419Test
https://unsworks.unsw.edu.au/bitstreams/cafa378b-e566-4efa-bf72-bbc3cca5523e/downloadTest -
4دورية أكاديمية
المؤلفون: Tohidi-Esfahani, I, Warden, A, Malunis, E, DeNardis, PL, Haurat, J, Black, M, Opat, S, Kee, D, D'Sa, S, Kersten, MJ, Spearing, RL, Palomba, ML, Olszewski, AJ, Harrington, C, Scott, CL, Trotman, J
العلاقة: Tohidi-Esfahani, I., Warden, A., Malunis, E., DeNardis, P. L., Haurat, J., Black, M., Opat, S., Kee, D., D'Sa, S., Kersten, M. J., Spearing, R. L., Palomba, M. L., Olszewski, A. J., Harrington, C., Scott, C. L. & Trotman, J. (2021). WhiMSICAL: A global Waldenstrom's Macroglobulinemia patient-derived data registry capturing treatment and quality of life outcomes. AMERICAN JOURNAL OF HEMATOLOGY, 96 (6), pp.E218-E222. https://doi.org/10.1002/ajh.26173Test.; http://hdl.handle.net/11343/298440Test
-
5دورية أكاديمية
المؤلفون: Kommoss, FKF, Cheasley, D, Wakefield, MJ, Scott, CL, Campbell, IG, Gilks, CB, Gorringe, K
العلاقة: Kommoss, F. K. F., Cheasley, D., Wakefield, M. J., Scott, C. L., Campbell, I. G., Gilks, C. B. & Gorringe, K. (2020). Primary mucinous ovarian neoplasms rarely show germ cell histogenesis. HISTOPATHOLOGY, 78 (4), pp.640-642. https://doi.org/10.1111/his.14297Test.; http://hdl.handle.net/11343/276792Test
-
6دورية أكاديمية
المؤلفون: Kondrashova, O, Scott, CL
العلاقة: NHMRC/1062702; Kondrashova, O. & Scott, C. L. (2019). Clarifying the role of EMSY in DNA repair in ovarian cancer. CANCER, 125 (16), pp.2720-2724. https://doi.org/10.1002/cncr.32135Test.; http://hdl.handle.net/11343/285898Test
-
7دورية أكاديمية
المؤلفون: Nesic, K, Wakefield, M, Kondrashova, O, Scott, CL, McNeish, IA
العلاقة: NHMRC/1062702; Nesic, K., Wakefield, M., Kondrashova, O., Scott, C. L. & McNeish, I. A. (2018). Targeting DNA repair: the genome as a potential biomarker. JOURNAL OF PATHOLOGY, 244 (5), pp.586-597. https://doi.org/10.1002/path.5025Test.; http://hdl.handle.net/11343/283468Test
-
8
المؤلفون: Nesic, K, Wakefield, M, Kondrashova, O, Scott, CL, McNeish, IA
مصطلحات موضوعية: Science & Technology, CANCER SUSCEPTIBILITY GENE, homologous recombination, mutational signatures, HOMOLOGOUS RECOMBINATION REPAIR, 1103 Clinical Sciences, PARP INHIBITOR, SOMATIC MUTATIONS, BRCA1, BRCA2, PROSTATE-CANCER, Oncology, DOUBLE-STRAND BREAK, UNCERTAIN SIGNIFICANCE, copy number signatures, POLY(ADP-RIBOSE) POLYMERASE INHIBITORS, Pathology, EPITHELIAL OVARIAN-CANCER, loss of heterozygosity, next-generation sequencing, TANDEM DUPLICATOR PHENOTYPE, ovarian high-grade serous carcinoma, Life Sciences & Biomedicine
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______1032::7b00e45a09e04864b009c74cdf1dbcdfTest
http://hdl.handle.net/10044/1/55470Test -
9دورية أكاديمية
المؤلفون: Scott, Cl, Iorgulescu, DG, Thorne, HJ, Henderson, MA, Phillips, KA
المصدر: Clinical Genetics ; volume 64, issue 2, page 111-121 ; ISSN 0009-9163 1399-0004